Press release
Global RNAi Drug Delivery Market Size, Share, Trends and Applications 2021
"Browse And Choose From Our World Class Research Reports"
Global RNAi Drug Delivery Market was worth USD 24.35 billion in 2016 and is expected to reach USD 81.07 billion by 2021 with a CAGR of 27.2 %. RNAi is a defense mechanism employed by Eukaryotes to degrade exogenous genes such as viruses. It is exclusively called gene silencing. We can initiate this by injecting RNAi-based drugs into the human body which is called RNAi Drug Delivery.
RNAi Drug Delivery is an emerging therapeutic method. This method is specific to the point and has fewer side effects. It is possible to cure cancer with this method by controlling gene mutation. From 2006 onwards various clinical trials are being held and people are investing billions in this market to approve and research various types of RNAi-based Drugs.
Full report at: http://www.marketdataforecast.com/market-reports/global-rnai-drug-delivery-market-1976/
Some factors like increasing prevalence of chronic diseases like cancer and heart diseases and innovative Applications of drug delivery market are driving this market. In addition, Research carried out in RNA Therapeutic field has also amplified the growth in Global RNA Drug Delivery Market. But, High investment and strict regulations are some of the major restraints to this market. Delivery of RNAi Drugs to specific tissues is the key challenge faced by the market.
Global RNAi Drug Delivery market is segmented based on Drug Delivery and Therapeutic Application. Based on Drug Delivery, this market is further segmented into nanoparticle drug delivery technology, nucleic acid drug delivery technology, aptamer drug delivery technology, and pulmonary drug delivery technology. Based on Therapeutic Application, the market is further segmented into infectious diseases, cardiology, oncology, neurology, ophthalmology and metabolic disorders. Nanoparticle Drug Delivery is largest sub-segment in this market because of its use in selected delivery of drugs. However, aptamer drug delivery technology is the fastest growing segment.
Market Segmentation:
• Drug delivery
• Therapeutic Application
Key Players:
• Alnylam Pharmaceuticals Inc.
• Merck & Co. Inc
• Access Pharmaceuticals Inc.
Based on Geography, this market is further segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. North America has the largest share in the market followed by Europe because of their high investments. However, Asia-Pacific market is expected to increase at highest CAGR in the following five years because of increasing investments by the major players in this region
Request sample: http://www.marketdataforecast.com/market-reports/global-rnai-drug-delivery-market-1976/request-sample
Key players in this region are Alnylam Pharmaceuticals Inc., Merck & Co. Inc, Access Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Tekmira Pharmaceuticals Corp., Isis Pharmaceuticals Inc, Calondo Pharmaceuticals Inc., Marina Biotech Inc., RXi Pharmaceuticals Corp., Quark Pharmaceuticals Inc., Silence Therapeutics plc, Traversa Therapeutics Inc., Tacere Therapeutics Inc., Sirnaomics Inc., and PhaseRx Inc.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global RNAi Drug Delivery Market Size, Share, Trends and Applications 2021 here
News-ID: 832857 • Views: …
More Releases from Market Data Forecast
Steam Methane Reforming Market Share, Industry Analysis & Forecast Report 2024-2 …
According to the latest research report published by Market Data Forecast, the global steam methane reforming market size was valued at USD 691.67 million in 2023 and is projected to reach USD 1004.13 million by 2029, growing at a CAGR of 6.41% during the forecast period 2024 to 2029.
Steam reforming of methane mainly involves two reactions: the water gas shift reaction and the reforming reaction. In the latter case, natural…
Telecom Tower Market is set for a Potential Growth
According to the latest research report published by Market Data Forecast, the global telecom tower market is predicted to reach USD 3.74 billion in 2024 and USD 7.07 billion by 2029, growing at a CAGR of 13.59% during the forecast period.
Telecom towers are the backbone of any mobile telecommunications system. The telecom tower is a structure that houses a transceiver to maintain connection with thousands of mobile phones and the…
Coke Oven Batteries Market Share, Industry Analysis & Forecast Report 2024-2029.
According to the latest research report published by Market Data Forecast, the global coke oven batteries market was valued at US$ 5.66 billion in 2023 and is predicted to reach US$ 30.24 billion by 2029, with a CAGR of 32.22% during the forecast period 2024 - 2029.
The coke oven battery includes battery machines and a group of coke ovens. Charging of coal into the furnace and unloading of coke from…
Marketing Automation Software Market is set for a Potential Growth Worldwide
According to the latest research report published by Market Data Forecast, global marketing automation software market is anticipated to be worth USD 12.89 billion by 2029 from USD 6.96 billion in 2024, growing at a CAGR of 13.12% from 2024 to 2029.
The marketing automation software market is experiencing strong growth, driven by rising demand for streamlined marketing operations. HubSpot, Market, and Salesforce are the dominant players in the market, providing…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
